Sfoglia per AUTORE
PATTI C
Collezione AO Ordine Mauriziano

  

Items : 20

High-dose chemotherapy and autologous stem cell transplant as first salvage treatment for relapsed or refractory Hodgkin Lymphoma in the era of PET-adapted strategies. in Leukemia & lymphoma / Leuk Lymphoma. 2024 Apr;65(4):460-471. doi: 10.1080/10428194.2023.2298273. Epub 2024 Jan 2.

2024
AO Ordine Mauriziano

Bagnardi V; Rambaldi A; Derenzini E; Sorio M; Gini G; Leotta S; Mulè A; Cocito F; Gottardi D; Rapezzi D; Lissandrini L; Tarella C; Marasco V; Sorasio R; Schiavotto C; Patti C; Romano A; Rossi A; Rusconi C; Frassoni S; Viviani S; Vanazzi A;

Early serum TARC reduction predicts prognosis in advanced-stage Hodgkin lymphoma patients treated with a PET-adapted strategy. in Hematological oncology / Hematol Oncol. 2020 Oct;38(4):501-508. doi: 10.1002/hon.2775. Epub 2020 Jul 30.

2020
AO Ordine Mauriziano
AO Cuneo

Gallamini A; Gianni AM; Corradini P; Galbiati M; Ferreri AJM; Farina L; Zanotti R; Cimminiello M; Tarella C; Gottardi D; Guidetti A; Sorasio R; Trentin L; Romano A; Patti C; Rossi A; Taverna F; Pavoni C; Mazzocchi A; Viviani S; Rambaldi A;

Early Chemotherapy Intensification With Escalated BEACOPP in Patients With Advanced-Stage Hodgkin Lymphoma With a Positive Interim Positron Emission Tomography/Computed Tomography Scan After Two ABVD Cycles: Long-Term Results of the GITIL/FIL HD 0607 Trial. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2018 Feb 10;36(5):454-462. doi: 10.1200/JCO.2017.75.2543. Epub 2018 Jan 23.

2018
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AO Cuneo
AOU Città della Salute di Torino

Rambaldi A; Gianni AM; Pavoni C; Chauvie S; Bergesio F; Prosperini G; Chiaravalloti A; Gregianin M; Ficola U; Fallanca F; Biggi A; Avigdor A; Billio A; Miglino M; Viero P; Ferreri AJM; Gini G; Zanotti R; Parvis G; Schiavotto C; Cimminiello M; Corradini P; Gavarotti P; Gottardi D; Battistini R; Rapezzi D; Bolis S; Trentin L; La Nasa G; et alii...

Randomized Trial Comparing R-CHOP Versus High-Dose Sequential Chemotherapy in High-Risk Patients With Diffuse Large B-Cell Lymphomas. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2016 Nov 20;34(33):4015-4022. doi: 10.1200/JCO.2016.67.2980. Epub 2016 Oct 31.

2016
AO Cuneo
AOU Città della Salute di Torino
AO Ordine Mauriziano

Rambaldi A; Boschini C; Delaini F; Masciulli A; Pileri S; Tabanelli V; Bruna R; Chilosi M; Falorio S; Flenghi L; Frezzato M; Trentin L; Gini G; La Nasa G; Benedetti F; Ferreri AJ; Di Raimondo F; Castellino C; Negri G; Piccin A; Billio A; Zoli V; Zanni M; Mulé A; Corradini P; Patti C; Di Nicola M; Gritti G; Rossi A; et alii...

High doses of antimetabolites followed by high-dose sequential chemoimmunotherapy and autologous stem-cell transplantation in patients with systemic B-cell lymphoma and secondary CNS involvement: Final results of a multicenter phase II trial in Journal of Clinical Oncology

2015
AO Ordine Mauriziano

Ferreri AJM; Donadoni G; Cabras MG; Patti C; Mian M; Zambello R; Tarella C; Di Nicola M; D'Arco AM; Doa G; Bruno-Ventre M; Assanelli A; Foppoli M; Citterio G; Fanni A; Mulè A; Caligaris-Cappio F; Ciceri F;

High doses of antimetabolites followed by high-dose sequential chemoimmunotherapy and autologous stem cell transplant in patients with systemic b-cell lymphoma and secondary central nervous system involvement: Final results of a multicenter Phase II trial in Haematologica

2015
AO Ordine Mauriziano

Bruno-Ventre M; Doa G; D'Arco AM; Di Nicola M; Tarella C; Zambello R; Mian M; Patti C; Cabras MG; Citterio G; Foppoli M; Ferreri AJM; Fanni A; Mulè A; Calimeri T; Ciceri F; Caligaris-Cappio F; Sassone M; Scarfò L;

Intensified chemo-immunotherapy with or without stem cell transplantation in newly diagnosed patients with peripheral T-cell lymphoma. in Leukemia / Leukemia. 2014 Sep;28(9):1885-91. doi: 10.1038/leu.2014.79. Epub 2014 Feb 20.

2014
AO Ordine Mauriziano
AO Cuneo
AOU Alessandria

Pileri S; Dodero A; Tarella C; Ferreri A; Patti C; Baldini L; Bruno B; Salvi F; Todeschini G; Rossi G; Benedetti F; Olivieri A; Gallamini A; Patriarca F; Miceli R; Rambaldi A; Corradini P; Vitolo U;

High doses of antimetabolites followed by high-dose sequential chemoimmunotherapy and autologous stem cell transplant in systemic B-cell lymphomas with CNS involvement: A multicenter phase II trial in Haematologica

2014
AO Ordine Mauriziano

Caligaris-Cappio F; Ciceri F; Mulè A; Pinotti G; Bruno Ventre M; Foppoli M; Fanni A; Di Nicola M; D'Arco AM; Doa G; Zambello R; Tarella C; Cabras MG; Patti C; Milan M; Ferreri AJ; Donadoni G;

Long-term results of the phase III GITMO/FIL trial of CHOP-R versus R-HDS plus autograft in high-risk follicular lymphoma (FL) at diagnosis in Journal of Clinical Oncology

2014
AO Ordine Mauriziano

Magni M; Ladetto M; Gueli A; Passera R; Bruna R; Corradini P; Zoli V; Perrone T; Stelitano C; Rossini F; Castellino C; Gini G; Liberati AM; Musso M; Pulsoni A; Barbui AM; Patti C; Boccomini C; Benedetti F; Tarella C;

Feasibility and efficacy of high doses of antimetabolites followed by high-dose sequential chemoimmunotherapy (R-HDS) and autologous stem cell transplant (ASCT) in patients (pts) with systemic B-cell lymphoma (BCL) and central nervous system (CNS) involvement: A multicenter phase II trial in Journal of Clinical Oncology

2014
AO Ordine Mauriziano

Caligaris-Cappio F; Ciceri F; Foppoli M; Fanni A; Doa G; Mulè A; Tarella C; Di Nicola MA; D'Arco A; Ventre MB; Mian M; Zambello R; Cabras MG; Patti C; Ferreri AJM; Donadoni G;

Intensified program including bendamustine, high dose therapy and autograft for patients with relapsed or resistant follicular non hodgkin lymphoma: Results from an exploratory gitil study in Hematological Oncology

2013
AO Ordine Mauriziano

Patti C; Mule' A; Barbui A; Tringali S; Costa A; Gueli A; Castellino C; Magni M; Dodero A; Leone M; Fabbiano F; Gallamini A; Corradini P; Gianni A; Tarella C; Rambaldi A; Scime' R;

The lymphocyte to monocyte ratio improves the IPI-risk definition of diffuse large B-cell lymphoma when rituximab is added to chemotherapy in American Journal of Hematology

2013
AO Ordine Mauriziano

Rambaldi A; Boschini C; Gritti G; Delaini F; Oldani E; Rossi A; Barbui AM; Caracciolo D; Ladetto M; Gueli A; De Crescenzo A; Passera R; Devizzi L; Patti C; Gianni AM; Tarella C;

Intensified chemo-immunotherapy including up-front autologous or allogeneic stem cell transplantation (SCT) for young patients with newly diagnosed peripheral T-cell lymphomas: Final results of a phase II multicenter prospective clinical trial in Blood

2012
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Corradini P; Vitolo U; Rambaldi A; Miceli R; Patriarca F; Gallamini A; Olivieri A; Benedetti F; Todeschini G; Rossi G; Parvis G; Salvi F; Bruno B; Baldini L; Patti C; Milone G; Ferreri AJM; Tarella C; Pileri SA; Dodero A;

High-dose sequential chemoimmunotherapy supported by autologous stem cell transplantation in patients with systemic B-cell lymphoma and central nervous system involvement: Interim analysis of a multicentre phase II Trial in Bone Marrow Transplantation

2011
AO Ordine Mauriziano

Marturano E; Patti C; Cabras MG; Cortelazzo S; Zambello R; Carrabba M; Mule A; Peccatori J; Ciceri F; Tarella C; Ferreri AJ;

Safety, tolerability and activity of ofatumumab, bendamustine and dexamethasone combination as first-line treatment of mantle-cell lymphoma in the elderly: A multicenter study in Blood

2011
AO Ordine Mauriziano

Magni M; Di Nicola M; Carlo-Stella C; Devizzi L; Guidetti A; Matteucci P; Viviani S; Zambelli S; Ferreri AJM; Rambaldi A; Di Raimondo F; Tarella C; Gallamini A; Nobile F; Vallisa D; Carella AM; Patti C; Quarta G; Rizzoli V; Benedetti F; Corradini P; Gianni AM;

Male gender, quality of grafted cells, advanced age, rituximab and radiotherapy are the main factors that variously influence the occurrence of secondary malignancies following high-dose therapy and autograft: A GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) survey in 1,347 lymphoma patients in Blood

2009
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Tarella C; Passera R; Magni M; Rossi A; Benedetti F; Gueli A; Patti C; Parvis G; Ciceri F; Gallamini A; Cortelazzo S; Corradini P; Zoli V; Mule A; Crocchiolo R; Bosa M; Barbui A; Di Nicola M; Caracciolo D; Sorio M; Gianni AM; Rambaldi A;

High response rate with favorable survival projections in high-risk patients with diffuse large B-cell lymphoma (DLBCL) receiving R-CHOP-14 or early intensified chemotherapy with rituximab and autograft (R-HDS): Results of the interim analysis of a gitil prospective multicenter phase III study in Blood

2009
AO Ordine Mauriziano

Cortelazzo S; Tarella C; Gianni AM; Ladetto M; Zanni M; Corradini P; Di Nicola M; Patti C; Mulè A; Majolino I; Billio A; Gueli A; Di Raimondo F; Chiarenza A; Gallamini A; Ferreri A; Pizzolo G; Benedetti F; La Nasa G; Leoni P; Gini G; Trentin L; Rodeghiero F; Marchioli R; Barbui T; Barbui A; Rambaldi A;

Factors influencing the occurrence of secondary myelodysplastic syndrome/acute leukemia following high-dose therapy and autograft: A GITIL (Gruppo Italiano Terapie innovative nei linfomi) survey in 1,347 lymphoma patients in Haematologica

2009
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Tarella C; Passera R; Magni M; Rossi A; Gueli A; Benedetti F; Patti C; Parvis G; Ciceri F; Gallamini A; Cortelazzo S; Corradini P; Zoli V; Leone M; Bosa M; Barbui A; Di Nicola M; Boccadoro M; Sorio M; Gianni AM; Rambaldi A;

Limited stage low-grade lymphoma patients receiving Rituximab combined with localized radiotherapy: The long-term follow-up shows prolonged survival with low incidence of disease recurrence in Haematologica

2009
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Tarella C; Caracciolo D; Ruella M; Bazzan M; Parvis G; Ladetto M; Boccadoro M; Mistretta A; Patti C; Todisco L; Franco P; Ricardi U; Filippi AR;

Histology and rituximab addition are the main factors influencing the long-term outcome in high-risk lymphoma following high-dose therapy and autograft: A 20-yr. Follow-up in 1,347 patients by gitil (gruppo italiano terapie innovative NEI Linfomi) in Haematologica

2009
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Tarella C; Di Nicola M; Rossi A; Caracciolo D; Passera R; Benedetti F; Patti C; Parvis G; Ciceri F; Castellino C; Cortelazzo S; Corradini P; Majolino I; Mule' A; Bosa M; Barbui A; Magni M; Boccadoro M; Sorio M; Rambaldi A; Gianni AM;